Specification:0.36gIndications:1.Treatment of influenza A and B in patients aged 2 weeks and older. Administration should begin within 48 hours of the first symptom onset.2.Prevention of influenza A and B in individuals aged 1 year and older.
CPHI制藥在線為您找到Oseltamivir Phosphate for Suspension 價格、Oseltamivir Phosphate for Suspension 詳細參數(shù)、Oseltamivir Phosphate for Suspension 相關產品、Oseltamivir Phosphate for Suspension 供應商等信息，想了解當前Oseltamivir Phosphate for Suspension 最新報價，請聯(lián)系江蘇萬高藥業(yè)股份有限公司。
2006-2025 上海博華國際展覽有限公司版權所有（保留一切權利）
滬ICP備05034851號-57
